[TVTX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
27-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- 0.99%
YoY- -104.79%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 50,983 46,687 43,771 42,177 37,326 30,447 14,085 23.88%
PBT -122,093 -30,227 -7,455 -11,038 -12,288 -12,994 -29,239 26.87%
Tax -471 32 -10,797 6,580 -3,685 -10,525 36,485 -
NP -121,622 -30,259 -7,455 -17,618 -8,603 -2,469 -29,239 26.78%
Tax Rate - - - - - - - -
Total Cost 172,605 76,946 51,226 59,795 45,929 32,916 43,324 25.88%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -238.55 -64.81 -17.03 -41.77 -23.05 -8.11 -207.59 2.34%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -2.37 -0.70 -0.18 -0.45 -0.23 -0.07 -1.08 13.98%
EPS Diluted -2.37 -0.69 -0.18 -0.44 -0.22 -0.07 -0.96 16.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.